Stay updated on Crisaborole Ointment for Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Crisaborole Ointment for Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crisaborole Ointment for Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents the number of participants who will be randomized to enter the double-blind maintenance treatment period in a study evaluating long-term maintenance treatment with crisaborole ointment for atopic dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:26.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that participants must be male or female, 3 months of age or older, with a confirmed diagnosis of atopic dermatitis and a minimum of 5% BSA affected. Previously, no information was provided in this section.
    Difference
    8%
    Check dated 2024-05-22T21:02:41.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T21:55:56.000Z thumbnail image

Stay in the know with updates to Crisaborole Ointment for Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crisaborole Ointment for Atopic Dermatitis Clinical Trial page.